In summary, the cumulative evidence in the literature of the relevance of PICH for the proliferation of different cancer cells, together with our results presented here using a Pich conditional KO model, indicate that PICH is a promising therapeutic target to treat BL and possibly other cancers with high PICH expression. The gene discussed is ERCC6L; the disease is Burkitt lymphoma.